Optimizing surveillance of low-risk metabolic dysfunction associated steatotic liver disease using transient

Harish Gopalakrishna1, Gayatri B Nair2, Roham Salman Roghani1,3

  • 1Liver & Energy Metabolism Section, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.

Abstract